v3.25.4
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:        
Research and development $ 1,724 $ 1,044 $ 5,684 $ 3,172
General and administrative 1,619 1,703 8,613 5,164
Total operating expenses 3,343 2,747 14,297 8,336
Loss from operations (3,343) (2,747) (14,297) (8,336)
Other income (expense):        
Interest expense 0 (45) 0 (130)
Interest income 82 80 248 247
Total other income, net 82 35 248 117
Loss before income taxes (3,261) (2,712) (14,049) (8,219)
Income taxes 0 0 0 0
Net loss $ (3,261) $ (2,712) $ (14,049) $ (8,219)
Loss per share - basic and diluted (in dollars per share) $ (0.36) $ (1.46) $ (2.41) $ (5.72)
Weighted average shares outstanding - basic and diluted (in shares) 8,955,809 1,851,910 5,835,213 1,437,982